PMID: 19232821

Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Cancer Lett. 2009 Jun 28;279(1):74-83. Epub 2009 Feb 18., 2009-06-28 [PubMed]
Sentences
No. Mutations Sentence Comment
26 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19232821:26:62
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19232821:26:39
status: VERIFIED
view ABCG2 p.Arg482Gly details
In contrast, cells carrying a glycine (R482G) or a threonine (R482T) at position 482 were able to transport rhodamine 123 and doxorubicin, while also maintained their ability to transport mitoxantrone. Login to comment
27 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19232821:27:85
status: VERIFIED
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19232821:27:58
status: VERIFIED
view ABCG2 p.Arg482Gly details
The ABCG2 variants were found in drug-resistant S1-M1-80 (R482G) and MCF-7 AdVp3000 (R482T) but not in the parental S1 and MCF-7 cell lines, suggesting that these were acquired mutations resulting from drug selection. Login to comment